CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Donovan Joanne M. CMO | Option exercise 10b5-1 | +28,662 | $7.08 | $203K | 38,259 |
| 2026-04-01 | Donovan Joanne M. CMO | Sale 10b5-1 | −28,662 | $32.31 | $926K | 9,597 |
| 2026-04-01 | Donovan Joanne M. CMO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −28,662 | 125,000 | ||
| 2026-03-31 | Donovan Joanne M. CMO | Option exercise 10b5-1 | +21,338 | $7.08 | $151K | 30,935 |
| 2026-03-31 | Donovan Joanne M. CMO | Sale 10b5-1 | −21,338 | $32.12 | $685K | 9,597 |
| 2026-03-31 | Donovan Joanne M. CMO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −21,338 | 153,662 | ||
| 2026-03-27 | Donovan Joanne M. CMO | Sale 10b5-1 | −9,623 | $30.98 | $298K | 16,332 |
| 2026-03-27 | Donovan Joanne M. CMO | Sale 10b5-1 | −6,735 | $30.98 | $209K | 9,597 |
| 2026-01-21 | Edris Badreddin Director | Option exercise 10b5-1 | +13,690 | $0.39 | $5K | 33,510 |
| 2026-01-21 | Edris Badreddin Director | Option exercise 10b5-1 | +17,236 | $0.64 | $11K | 50,746 |
| 2026-01-21 | Edris Badreddin Director | Option exercise 10b5-1 | +10,463 | $1.93 | $20K | 61,209 |
| 2026-01-21 | Edris Badreddin Director | Option exercise 10b5-1 | +66,477 | $1.93 | $128K | 127,686 |
| 2026-01-21 | Edris Badreddin Director | Option exercise 10b5-1 | +7,605 | $0.71 | $5K | 135,291 |
| 2026-01-21 | Edris Badreddin Director | Sale 10b5-1 | −13,690 | $29.44 | $403K | 121,601 |
| 2026-01-21 | Edris Badreddin Director | Sale 10b5-1 | −17,236 | $29.44 | $507K | 104,365 |
| 2026-01-21 | Edris Badreddin Director | Sale 10b5-1 | −7,605 | $29.44 | $224K | 96,760 |
| 2026-01-21 | Edris Badreddin Director | Sale 10b5-1 | −10,463 | $29.44 | $308K | 86,297 |
| 2026-01-21 | Edris Badreddin Director | Sale 10b5-1 | −66,477 | $29.44 | $2.0M | 19,820 |
| 2026-01-21 | Edris Badreddin Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,463 | 0 | ||
| 2026-01-21 | Edris Badreddin Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −66,477 | 0 |
Page 5 of 26 · 509 trades